“…Apx I, expressed and secreted by serotypes 1,5,9,10 and 11, has strong hemolytic activity, and strong cytotoxic effects on alveolar macrophages and neutrophils, and is one of the potent protective antigens for APP (Meyns et al 2007). The production, activation, and secretion activity of ApxI is regulated by an operon that includes the above four complete CABD genes: ApxIC, ApxIA, ApxIB and ApxID, a typical operon of RTX toxin, and the product of ApxI is responsible for secretion to extracellular (Nkando et al 2012;Li et al 2022). Serotypes l, 5a, 5b, 9, 10 and 11 are clinically APP outbreak serotypes with severe lung injury and high mortality, and strong hemolytic and cytotoxic ApxI because they have intact ApxI, while serotypes 2,4,6,7,8 and 12, although not producing ApxI, have a truncated ApxI retaining the original promoter whose expressed products have secretory functional (Nielsen R et al 2000).…”